Establishes a program to increase participation by certain demographic groups in clinical trials. (BDR 40-707)
Bill status
signed
all 5 stages cleared
Introduction
Feb 2017
Committee Review
May 2017
Assembly Passage
May 2017
Senate Passage
May 2017
Signed into Law
May 2017
Introduced Feb 13, 2017
Signed May 26, 2017
Floor votes · Assembly Apr 13, 2017
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
21
Key actions
7
Committee
3
May 26, 2017
Signed into law
Approved by the Governor. Chapter 142.
executive
May 18, 2017
Lower · Passed
Senate Amendment No. 671 concurred in. To enrollment.
lower
May 17, 2017
Upper · Passed
Read third time. Passed, as amended. Title approved. (Yeas: 21, Nays: None.) To Assembly.
upper
May 16, 2017
Upper · Passed
From committee: Amend, and do pass as amended.
upper
Apr 13, 2017
Lower · Passed
Read third time. Passed, as amended. Title approved. (Yeas: 42, Nays: None.) To Senate.
lower
Apr 10, 2017
Lower · Passed
From committee: Amend, and do pass as amended.
lower
Feb 15, 2017
Lower · Passed
From printer. To committee.
lower
Feb 13, 2017
Introduced
Prefiled pursuant to JSR 14.2.1(d).
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dina Neal
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about AB 214
Scope: NV
Hi! I can help you understand AB 214. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline